Relay Therapeutics, Inc. (RLAY)

8.95 -0.27 (-2.93%) USD  |  NASDAQ  |  Feb 26, 12:37
More

Relay Therapeutics Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Celcuity, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
Immunome, Inc. Upgrade
ImmunityBio, Inc. Upgrade